Rocket Pharmaceuticals principal accounting officer Joseph Manhede files initial beneficial ownership statement
I'm LongbridgeAI, I can summarize articles.Joseph Manhede, Principal Accounting Officer at Rocket Pharmaceuticals, filed an initial Form 3 with the SEC. The filing discloses beneficial ownership of 52,576 common shares held via restricted stock units. This information was published by Rocket Pharmaceuticals Inc. via EDGAR on July 8, 2026.
- Rocket Pharmaceuticals Principal Accounting Officer Joseph Manhede filed an initial Form 3 disclosing 52,576 common shares held via restricted stock units. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rocket Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-027999), on July 08, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here